Taiwan’s COVID-19 outbreak continued to batter domestic demand last month, especially in the food and beverage sector, the Ministry of Economic Affairs said yesterday.
Food and beverage sales were NT$42.6 billion (US$1.52 billion), up 11.1 percent month-on-month but down 38.8 percent year-on-year, as the nation was under a level 3 COVID-19 alert for most of the month and dine-in services only took off gradually afterward.
“In July last year, the food and beverage sector was starting a proper recovery from the initial shock of the COVID-19 pandemic,” Department of Statistics Deputy Director-General Huang Wei-jie (黃偉傑) said. “However, this July, it was still bearing the full brunt of a more serious outbreak.”
Photo: Lin Hsin-de, Taipei Times
Despite the COVID-19 alert being lowered to level 2 with the resumption of dine-in services in many cities, including Taipei and New Taipei City, Huang said that recovery of sales in the food and beverage sector would be sluggish.
“We might need to wait for the next round of stimulus vouchers before we see a more comprehensive recovery in the food and beverage sector,” Huang said.
The retail sector was also affected by COVID-19 restrictions, although to a lesser degree, the ministry said.
Retail sales totaled NT$301.5 billion, down 10.3 percent year-on-year but up 13.2 percent month-on-month, ministry data showed.
E-commerce platforms benefited from the pandemic-driven economy, with sales increasing 23.4 percent year-on-year to NT$23.5 billion, as did supermarkets, with sales rising 19.9 percent to NT$23 billion, and big-box stores, with sales rising 9.1 percent to NT$21.1 billion — each achieving a July record, the ministry said.
The nation’s wholesale sector bucked the trend by smashing a July record with sales of NT$1.063 trillion, up 11.1 percent year-on-year, which Huang attributed to continued high demand for 5G and artificial intelligence applications, and remote working devices, as well as the rising cost of raw materials.
“Most of the orders for wholesalers came from overseas amid a global economic recovery,” Huang said. “Wholesalers benefited more from overseas markets and were less affected by the local COVID-19 outbreak.”
In the first seven months of the year, food and beverage sales fell 7.4 percent year-on-year to NT$404.1 billion, while retail sales rose 3.3 percent to NT$2.22 trillion and wholesale trade increased 17.3 percent to NT$6.83 trillion, ministry data showed.
Malaysia is scrambling to protect its assets as the descendants of the last sultan of the remote Philippine region of Sulu look to enforce a US$15 billion arbitration award in a dispute over a colonial-era land deal. In 1878, two European colonists signed a deal with the sultan for the use of his territory in present-day Malaysia — an agreement that independent Malaysia honored until 2013, paying the monarch’s descendants about US$1,000 per year. Now, 144 years later after the original deal, Malaysia is on the hook for the second-largest arbitration award on record for stopping the payments after a bloody incursion
RECOVERED CONFIDENCE: As market rationality returns, Taiwanese stocks that have lagged behind their US peers might soon catch up, Allianz researchers said Local shares last week defied heavy pressure from China’s military drills in waters around Taiwan, and investors this week are expected to pay attention to earnings results from several tech heavyweights as well as the latest economic data on exports and GDP. The TAIEX closed at 15,036.04 points on Friday, posting a weekly increase of 0.24 percent from 15,000.07 on July 29, Taiwan Stock Exchange data showed. Over the same period, the FTSE TWSE Taiwan 50 Index, which comprises Taiwan’s top 50 stocks in terms of market capitalization, closed up 0.93 percent at 11,750.15 points, while the Formosa Stock Index, which measures
Pharmaceutical start-up AcadeMab Biomedical Inc (研生生醫) said it has been developing a COVID-19 antibody drug, an endeavor not being undertaken by many other Taiwanese pharmaceutical firms. The company was spun off from Academia Sinica’s Institute of Cellular and Organismic Biology in 2020 and has only 16 employees. It has set its sights on the innovative field of the monoclonal antibody treatment of tumors. The start-up began developing antibody drugs in January, after seeing that COVID-19 vaccines could not effectively protect people from new variants of SARS-CoV-2, AcadeMab Biomedical chief strategy officer Pearl Fong (俸清珠) said in an interview with the Taipei Times
FORECAST EXCEEDED: China’s curbs on some Taiwanese goods are unlikely to affect trade given inter-reliance in the electronics industries, a finance ministry official said Exports last month spiked 14.2 percent to US$43.32 billion, the second-highest increase on record and the 25th consecutive month of gains, driven by global demand for electronics used in high-performance computing and vehicles, the Ministry of Finance said yesterday. The ministry expects the trend to sustain this month and beyond, although the pace could slow due to inventory corrections for laptops, smartphones and other consumer electronics. “The July results proved stronger than expected despite rising fears over economic uncertainty,” Department of Statistics Director-General Beatrice Tsai (蔡美娜) said, adding that a high sales season in the West and stabilized COVID-19 infections in China
RSS